Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Therapeutic Advances in Neurological Disorders
|
December 25, 2025
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study)
Gloria Vaghi, Luigi Francesco Iannone, Michele Corrado, et al.
Frontiers in Neurology
|
September 22, 2025
Sex differences in the clinical features of 2,841 patients with migraine: a <i>post-hoc</i>, multicenter, cross-sectional study
Marina Romozzi, Luigi Francesco Iannone, Marcello Silvestro, et al.
Cephalalgia : an International Journal of Headache
|
June 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study)
Claudia Altamura, Luigi Francesco Iannone, Flavia Lo Castro, et al.
Cephalalgia : an International Journal of Headache
|
March 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability
Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis, et al.
Cephalalgia : an International Journal of Headache
|
February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)
Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
The Journal of Headache and Pain
|
October 2, 2025
Hallmarks of primary headache: part 3 - cluster headache
Gianluca Coppola, Marco Antônio Arruda, Messoud Ashina, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Therapeutic Advances in Neurological Disorders
|
December 25, 2025
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study)
Gloria Vaghi, Luigi Francesco Iannone, Michele Corrado, et al.
Frontiers in Neurology
|
September 22, 2025
Sex differences in the clinical features of 2,841 patients with migraine: a <i>post-hoc</i>, multicenter, cross-sectional study
Marina Romozzi, Luigi Francesco Iannone, Marcello Silvestro, et al.
Cephalalgia : an International Journal of Headache
|
June 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study)
Claudia Altamura, Luigi Francesco Iannone, Flavia Lo Castro, et al.
Cephalalgia : an International Journal of Headache
|
March 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability
Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis, et al.
Cephalalgia : an International Journal of Headache
|
February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)
Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
The Journal of Headache and Pain
|
October 2, 2025
Hallmarks of primary headache: part 3 - cluster headache
Gianluca Coppola, Marco Antônio Arruda, Messoud Ashina, et al.
Page
of 4